[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@StockwatchDK "Says: We acknowledge the significant uncertainty surrounding rsted's offshore activities in the US but expect the company to at least complete Revolution Wind which should limit the financial risk of further government intervention"
X Link @StockwatchDK 2025-10-10T08:28Z XX followers, XX engagements

"Danske Bank expects rsted to announce farm-downs of Hornsea X and Greater Changhua X and see it capable of handling a worst-case scenario for Revolution and Sunrise Wind. There are still challenges to overcome but Danske Bank also sees value at current levels"
X Link @StockwatchDK 2025-10-09T09:47Z XX followers, XX engagements

"Bernstein says M&A risk could overhang as pro-forma cliff steeper; Genmab will be pro-forma net cash in 2029; maintains Underperform with DKK1015 PT on 6x PE28 discount to peers"
X Link @StockwatchDK 2025-10-09T08:46Z XX followers, XX engagements

"Handelsbanken is making a change to its sector favorites within Healthcare with Getinge becoming one of the sector favorites. Danish Genmab is Handelsbanken's first choice in the sector which means that Novo Nordisk is removed from the list after a return of XX percent"
X Link @StockwatchDK 2025-10-10T08:32Z XX followers, XXX engagements

"Says on Genmab: Royalties for Darzalex will likely peak in 2028 and decline until 2031 when they will cease. With good visibility regarding Darzalex and given the tax rate of XX percent it is easy to reach a net present value after tax of approximately DKK 1000 per share"
X Link @StockwatchDK 2025-10-10T08:34Z XX followers, XX engagements

"SEB Nordea Danske Bank and Handelsbanken are due to hold so-called pre-close calls for analysts next week ahead of third-quarter earnings season which starts mid-October-"
X Link @StockwatchDK 2025-09-26T10:14Z XX followers, XX engagements

"IQVIA new-to-brand (NBRx) trends for the starter doses of obesity GLP-1s in the US market for the week ending 3rd October: Total Novo Nordisk GLP-1 NBRx increased +8.5% w/w vs Eli Lilly increased +1.7% w/w (all doses)"
X Link @StockwatchDK 2025-10-13T20:54Z XX followers, XX engagements

"Danske Bank downgrades DFDS to Sell from Hold and reduces the target price to XX DKK from XX DKK expects Q3 to be a weak quarter and says competition will make DFDS make a profit warning"
X Link @StockwatchDK 2025-10-10T08:43Z XX followers, XX engagements

"Handelsbanken continues to have a positive view on Novo Nordisk with a Buy recommendation but now sees greater risk-adjusted upside in Genmab and Getinge"
X Link @StockwatchDK 2025-10-10T08:33Z XX followers, XXX engagements